ACMG Announces New Leadership Board and President-Elect for 2025

The American College of Medical Genetics and Genomics Welcomes New Leadership

The American College of Medical Genetics and Genomics (ACMG) took a significant step forward at its Annual Clinical Genetics Meeting held in Los Angeles, California, announcing the induction of six new directors, including a groundbreaking president-elect. This announcement underscores the organization's commitment to advancing genetic medicine, marking a pivotal evolution in its leadership.

As part of an extensive leadership overhaul, the newly elected members will serve six-year terms beginning in March 2025 through March 2031. This transition comes as a heartfelt farewell to the outgoing members, including geneticists Marc Williams, Heidi Rehm, Karen Gripp, Dieter Matern, Michael Murray, and Cynthia Powell, each of whom has made notable contributions during their terms.

ACMG President, Dr. Susan Klugman, expressed her optimism about the incoming board, stating, "Our new board members come with a wealth of experience and fresh ideas. They have demonstrated a deep commitment to the College through various roles and initiatives, which will be essential for shaping the future." This election is particularly historic as it introduces the first-ever PhD to serve as president-elect, and marks a notable moment with all of the organization's top leadership roles being held by women.

Introducing the New President-Elect: Dr. Christa L. Martin

Dr. Christa L. Martin, the newly elected president-elect, currently holds critical roles as the Chief Scientific Officer at Geisinger and Vice Dean for Research at Geisinger’s School of Medicine. With over 20 years in genetic medicine, Dr. Martin's work primarily focuses on implementing genomics into routine healthcare, especially for neurodevelopmental and psychiatric disorders. Her extensive background includes the pioneering MyCode Community Health Initiative, recognized as one of the most ambitious genomic sequencing projects worldwide.

Dr. Martin has become a highly regarded figure in genetic research, authoring more than 170 publications. She intends to leverage her unique experiences in both clinical and research settings to advance ACMG's mission: integrating genetics and genomics into comprehensive health strategies. "My focus will be on aligning genomic advancements with practical applications in patient care," Dr. Martin shared.

Other Newly Elected Board Members

1. Dr. Josh Deignan: A seasoned expert in clinical genetics and a Clinical Professor at UCLA, Dr. Deignan brings vast experience from various ACMG committees, focusing on molecular genetics and laboratory quality assurance.
2. Dr. Lauren J. Massingham: Specializing in pediatric and adult genetic conditions at Hasbro Children's Hospital, Dr. Massingham has directed significant initiatives in hereditary cancer genetics, expanding education in genetics for medical professionals.
3. Dr. David T. Miller: Serving at Boston Children's Hospital, Dr. Miller is known for his work in neurodevelopmental disorders and role in handling ACMG's Secondary Findings Maintenance Working Group.
4. Dr. Douglas R. Stewart: With over 25 years dedicated to clinical genetics and cancer risk assessment, Dr. Stewart, who also works at the National Cancer Institute, has been influential in studying the connection between germline variants and cancer risk.
5. Dr. William R. Wilcox: With extensive expertise in biochemical genetics, Dr. Wilcox is known for his leadership in clinical genetics training and various research endeavors in metabolic disorders.

Together, these newly elected board members embody a diverse expertise essential in guiding ACMG's mission for the future. Dr. Klugman added, "With fresh perspectives and innovative ideas, we are poised to embark on a transformative journey for medical genetics and genomics."

As ACMG embarks on this new chapter, the organization is set to continue its advocacy for integrating genetics into mainstream medical practice, ensuring that it remains a critical pillar in advancing healthcare through genetics. The impact of the new leadership is anticipated to resonate within the field and beyond, potentially shaping the future of genetic medicine for years to come.

For more information on ACMG and its initiatives, visit their website at acmg.net.